The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
The Interaction Between Signal Regulatory Protein Alpha (SIRPα) and CD47: Structure, Function, and Therapeutic Target
Abstract
CD47 is a broadly expressed membrane protein that interacts with the myeloid inhibitory immunoreceptor SIRPα (also termed CD172a or SHPS-1). SIRPα is the prototypic member of the SIRP paired receptor family of closely related SIRP proteins. Engagement of SIRPα by CD47 provides a downregulatory signal that inhibits host cell phagocytosis, and CD47 therefore functions as a “don't-eat-me” signal. Here, we discuss recent structural analysis of CD47-SIRPα interactions and implications of this for the function and evolution of SIRPα and paired receptors in general. Furthermore, we review the proposed roles of CD47-SIRPα interactions in phagocytosis, (auto)immunity, and host defense, as well as its potential significance as a therapeutic target in cancer and inflammation and for improving graft survival in xenotransplantation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Of note, in some preclinical and clinical instances, the activity of surface-exposed CALR is antagonized by CD47, which operates as a “don’t eat me” signal as it inhibits phagocytosis by DCs and macrophages upon interaction with signal regulatory protein alpha (SIRPA) [885, 886].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [885]
Citations
Cites
Role of CD47 as a Marker of Self on Red Blood Cells
Oldenborg, P., Zheleznyak, A., Fang, Y., Lagenaur, C. F., Gresham, H. D., & Lindberg, F. P. (2000) · Science · doi:10.1126/science.288.5473.2051 · Cited by 2,018
Majeti, R., Chao, M. P., Alizadeh, A. A., Pang, W. W., Jaiswal, S., Gibbs, K. D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.045 · Cited by 1,752
Willingham, S. B., Volkmer, J.-P., Gentles, A. J., Sahoo, D., Dalerba, P. D., Mitra, S. S., Wang, J., Contreras-Trujillo, H., Martin, R. K., Cohen, J. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121623109 · Cited by 1,706
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Jaiswal, S., Jamieson, C. H. M., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D. J., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.046 · Cited by 1,578
Licensing of natural killer cells by host major histocompatibility complex class I molecules
Kim, S., Poursine‐Laurent, J., Truscott, S. M., Lybarger, L. P., Song, Y.-J., Yang, L., French, A. R., Sunwoo, J. B., Lemieux, S., Hansen, T. H., et al. (2005) · Nature · doi:10.1038/nature03847 · Cited by 1,328
Chao, M. P., Alizadeh, A. A., Tang, C. Z., Myklebust, J. H., Varghese, B., Gill, S. I., Jan, M., Cha, A. C., Chan, C. K. F., Tan, B. T., et al. (2010) · Cell · doi:10.1016/j.cell.2010.07.044 · Cited by 1,124
Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
Rodriguez, P. L., Harada, T., Christian, D. A., Pantano, D. A., Tsai, R. K., & Discher, D. E. (2013) · Science · doi:10.1126/science.1229568 · Cited by 1,001
Integrin-associated protein (CD47) and its ligands
Brown, E. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01906-1 · Cited by 880
Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system
Agrawal, A., Eastman, Q. M., & Schatz, D. G. (1998) · Nature · doi:10.1038/29457 · Cited by 811
Chao, M. P., Jaiswal, S., Weissman-Tsukamoto, R., Alizadeh, A. A., Gentles, A. J., Volkmer, J., Weiskopf, K., Willingham, S. B., Raveh, T., Park, C. Y., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001375 · Cited by 776
Research works printed but not linked: 5
- Vernon-Wilson EF, 2000, Eur. J. Immunol., 30, 2130
- Campbell IG, 1992, Cancer Res., 52, 5416
- Carter-Su C, 2000, Recent Prog. Horm. Res., 55, 293
- Stacey KJ, 2000, Curr. Top. Microbiol. Immunol., 247, 41
- Uno S, 2007, Oncol. Rep., 17, 1189
Cited by
Sorted by citations
Items 301–400 of 847
Wu, M., Chen, T., Wang, L., Akakuru, O. U., Ma, X., Xu, J., Hu, J., Chen, J., Fang, Q., Wu, A., et al. (2022) · Nanoscale · doi:10.1039/d2nr00985d · Cited by 32
Wang, D., Lin, Y., Xu, F., Zhang, H., Zhu, X., Liu, Z., Hu, Y., Dong, G., Sun, B., Yu, Y., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104278 · Cited by 32
Monocyte-Derived Macrophages Are Impaired in Myelodysplastic Syndrome
Han, Y., Wang, H., & Shao, Z. (2016) · Journal of Immunology Research · doi:10.1155/2016/5479013 · Cited by 32
Sun, J., Lei, L., Tsai, C., Wang, Y., Shi, Y., Ouyang, M., Lu, S., Seong, J., Kim, T., Wang, P., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00569-6 · Cited by 32
Saito, Y., Respatika, D., Komori, S., Washio, K., Nishimura, T., Kotani, T., Murata, Y., Okazawa, H., Ohnishi, H., Kaneko, Y., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711345114 · Cited by 32
Loss of CD47 alters CD8+ T cell activation in vitro and immunodynamics in mice
Nath, P. R., Pal-Nath, D., Kaur, S., Gangaplara, A., Meyer, T. J., Cam, M. C., & Roberts, D. D. (2022) · OncoImmunology · doi:10.1080/2162402x.2022.2111909 · Cited by 31
Hayes, A. J., & Melrose, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021148 · Cited by 33
Microglia-Centered Combinatorial Strategies Against Glioblastoma
Martins, T. A., Schmassmann, P., Shekarian, T., Boulay, J., Ritz, M., Zanganeh, S., Berg, J. V., & Hütter, G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.571951 · Cited by 32
Innate allorecognition in transplantation
Abou‐Daya, K. I., & Oberbarnscheidt, M. H. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.03.018 · Cited by 33
Minipigs in Translational Immunosafety Sciences
Rubic-Schneider, T., Christen, B., Brees, D., & Kammuller, M. E. (2016) · Toxicologic Pathology · doi:10.1177/0192623315621628 · Cited by 30
Ponce, L. P., Fenn, N. C., Moritz, N., Krupka, C., Kozik, J.-H., Lauber, K., Subklewe, M. S., & Hopfner, K. (2017) · Oncotarget · doi:10.18632/oncotarget.14500 · Cited by 30
Slee, J. B., Christian, A. J., Levy, R. J., & Stachelek, S. J. (2014) · Polymers · doi:10.3390/polym6102526 · Cited by 29
Léon-Letelier, R. A., Bonifaz, L. C., & Fuentes‐Pananá, E. M. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0618-241rr · Cited by 30
IFN-γ–Dependent Reduction of Erythrocyte Life Span Leads to Anemia during Mycobacterial Infection
Gomes, A. C., Moreira, A. C., Silva, T., Neves, J. V., Mesquita, G., Almeida, A. A., Barreira‐Silva, P., Fernandes, R., Resende, M., Appelberg, R., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900382 · Cited by 30
Liu, J., Tang, M., Harkin, K., Du, X., Luo, C., Chen, M., & Xu, H. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24618 · Cited by 29
Zheng, D., Wang, Z., Sui, L., Xu, Y., Wang, L., Qiao, X., Cui, W., Jiang, Y., Zhou, H., Tang, L., et al. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155581 · Cited by 29
Erythrocyte-enabled immunomodulation for vaccine delivery
Wang, F., Zong, R., & Chen, G. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.035 · Cited by 29
Harnessing Macrophages through the Blockage of CD47: Implications for Acute Myeloid Leukemia
Garcia, L. M., & Barabé, F. (2021) · Cancers · doi:10.3390/cancers13246258 · Cited by 29
Blocking CD47-SIRPα Signal Axis as Promising Immunotherapy in Ovarian Cancer
Luo, X., Shen, Y., Huang, W., Bao, Y., Mo, J., Yao, L., & Yuan, L. (2023) · Cancer Control · doi:10.1177/10732748231159706 · Cited by 30
Faralli, J. A., Desikan, H., Peotter, J. L., Kanneganti, N., Weinhaus, B., Filla, M. S., & Peters, D. M. P. (2019) · Europe PMC (PubMed Central) · Cited by 28
Liang, J., Wang, C., Fan, J., Xie, Q., Yu, Z., Liu, B., Tian, Y., Ning, J., Feng, L., Wang, W., et al. (2022) · Materials Today Advances · doi:10.1016/j.mtadv.2022.100245 · Cited by 28
Liu, S., Xiao, X., La, Z., Wang, J., Zhao, W., Liu, H., Liao, R., Li, Z., Xu, M., Guo, J., et al. (2023) · Theranostics · doi:10.7150/thno.88061 · Cited by 28
Moon, S., Han, S., Jang, I.-H., Ryu, J., Rha, M.-S., Cho, H., Yoon, S. S., Nam, K. T., Kim, C., Park, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47963-5 · Cited by 27
Efferocytosis: the resolution of inflammation in cardiovascular and cerebrovascular disease
Zhang, B., Zou, Y., Yuan, Z., Jiang, K., Zhang, Z., Chen, S., Zhou, X., Wu, Q., & Zhang, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1485222 · Cited by 30
Leung, C. S., Li, J., Xu, F., Wong, A. S. L., & Lui, K. O. (2018) · The FASEB Journal · doi:10.1096/fj.201800449r · Cited by 27
Aertker, B. M., Kumar, A., Prabhakara, K. S., Smith, P., Furman, N. E. T., Hasen, X., Cox, C. S., & Bedi, S. S. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24395 · Cited by 27
Koga, N., Hu, Q., Sakai, A., Takada, K., Nakanishi, R., Hisamatsu, Y., Ando, K., Kimura, Y., Oki, E., Oda, Y., et al. (2021) · Cancer Science · doi:10.1111/cas.14971 · Cited by 27
Garcia-Fabiani, M. B., Haase, S., Comba, A., Carney, S. V., McClellan, B. L., Banerjee, K., Alghamri, M. S., Faisal, S. M., Kadiyala, P., Núñez, F. J., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.631037 · Cited by 30
CD47-targeting antibodies as a novel therapeutic strategy in hematologic malignancies
Sun, J., Chen, Y., Lubben, B., Adebayo, O., Muz, B., & Azab, A. K. (2021) · Leukemia Research Reports · doi:10.1016/j.lrr.2021.100268 · Cited by 27
Dendritic cell SIRPα regulates homeostasis of dendritic cells in lymphoid organs
Washio, K., Kotani, T., Saito, Y., Respatika, D., Murata, Y., Kaneko, Y., Okazawa, H., Ohnishi, H., Fukunaga, A., Nishigori, C., et al. (2015) · Genes to Cells · doi:10.1111/gtc.12238 · Cited by 27
Bedoui, Y., Neal, J. W., & Gasque, P. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9793-6 · Cited by 28
Structural–functional diversity of CD47 proteoforms
Zhang, T., Wang, F., Xu, L., & Yang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1329562 · Cited by 26
Multifaceted, unique role of CD11c in leukocyte biology
Hou, L., Koutsogiannaki, S., & Yuki, K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1556992 · Cited by 27
Hu, Q., Shi, Y., Wang, H., Li, B., & Xu, Z. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00627-6 · Cited by 27
Sha, H., Li, R., Bian, X., Liu, Q., Xie, C., Xin, X., Kong, W., Qian, X., Jiang, X., Hu, W., et al. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.05.020 · Cited by 27
CD47 interactions with exportin-1 limit the targeting of m7G-modified RNAs to extracellular vesicles
Kaur, S., Saldana, A. C., ELKAHLOUN, A. G., Petersen, J. D., Arakelyan, A., SINGH, S. P., Jenkins, L. M. M., Kuo, B., Reginauld, B., Jordan, D. G., et al. (2021) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-021-00646-y · Cited by 27
Immune Escape Strategies in Head and Neck Cancer: Evade, Resist, Inhibit, Recruit
Kostecki, K. L., Iida, M., Crossman, B. E., Salgia, R., Harari, P. M., Bruce, J. Y., & Wheeler, D. L. (2024) · Cancers · doi:10.3390/cancers16020312 · Cited by 26
Rivera, A. M., Fu, X., Tao, L., & Zhang, X. (2015) · BMC Cancer · doi:10.1186/s12885-015-1980-8 · Cited by 26
Ye, X., Zhang, J., Lü, R., & Zhou, G. (2016) · Oncotarget · doi:10.18632/oncotarget.12874 · Cited by 26
Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor Immunity
Dheilly, E., Majocchi, S., Moine, V., Didelot, G., Broyer, L., Calloud, S., Malinge, P., Chatel, L., Ferlin, W. G., Kosco‐Vilbois, M. H., et al. (2018) · Antibodies · doi:10.3390/antib7010003 · Cited by 26
Cytokine-induced killer cells: new insights for therapy of hematologic malignancies
Sevari, F. G., Mehdizadeh, A., Abbasi, K., Hejazian, S. S., & Raeisi, M. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03869-z · Cited by 25
Understanding the complexity of tumor-associated macrophages: Druggable and therapeutic insights
Li, A.-Q., Huang, F., Talaiti, S., Yang, X. Y., Bi, H., & Fang, J. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.021 · Cited by 26
Targeting phagocytosis checkpoints for cancer immunotherapy
Veillette, A., Li, J., Galindo, C. C., Davidson, D., & Tang, Z.-H. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00893-w · Cited by 26
Epigenetics in Multiple Sclerosis
Chan, V. S. F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-3449-2_12 · Cited by 27
An antitumor peptide RS17‐targeted CD47, design, synthesis, and antitumor activity
Wang, X., Wang, Y., Hu, J., & Xu, H. (2021) · Cancer Medicine · doi:10.1002/cam4.3768 · Cited by 25
The ‘Danse Macabre’—Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes
Hadjigol, S., Shah, B. A., & O’brien-simpson, N. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.894021 · Cited by 26
Cong, L., Sugden, S., Leclair, P., Lim, C. J., Pham, T. N. Q., & Cohen, É. A. (2021) · mBio · doi:10.1128/mbio.01920-21 · Cited by 27
Pan, L., Wang, B., Chen, M., Ma, Y., Cui, B., Chen, Z., Song, Y., Hu, L., & Jiang, Z. (2022) · Cell Proliferation · doi:10.1111/cpr.13361 · Cited by 24
Vitale, C., Bottino, C., & Castriconi, R. (2023) · Cells · doi:10.3390/cells12060885 · Cited by 25
Liang, D.-M., Li, Y., Zhang, J., Shen, H.-H., Wu, C.-X., Xie, N., Liang, Y., Li, Y., Xue, J., Sun, H., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-05854-x · Cited by 25
Sakano, Y., Sakano, K., Hurrell, B. P., Shafiei-Jahani, P., Kazemi, M. H., Li, X., Shen, S. M.-C., Barbers, R. G., & Akbari, O. (2024) · Cellular and Molecular Immunology · doi:10.1038/s41423-024-01208-z · Cited by 24
Early SIV and HIV infection promotes the LILRB2/MHC-I inhibitory axis in cDCs
Alaoui, L., Palomino, G., Zurawski, S., Zurawski, G., Coindre, S., Dereuddre‐Bosquet, N., Lécuroux, C., Goujard, C., Vaslin, B., Bourgeois, C., et al. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2712-9 · Cited by 24
Boettcher, A. N., Cunnick, J. E., Putz, E. J., Egner, T. K., Charley, S. E., Loving, C. L., & Tuggle, C. K. (2018) · Xenotransplantation · doi:10.1111/xen.12466 · Cited by 24
A combined “eat me/don’t eat me” strategy based on exosome for acute liver injury treatment
Du, W., Chen, C., Liu, Y., Quan, H., Xu, M., Liu, J., Song, P., Fang, Z., Yue, Z. H., Xu, H., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102033 · Cited by 26
Billerhart, M., Schönhofer, M., Schueffl, H. H., Polzer, W., Pichler, J., Decker, S., Taschauer, A., Maier, J., Anton, M., Eckmann, S., et al. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.09.005 · Cited by 23
Innate Allorecognition Results in Rapid Accumulation of Monocyte-Derived Dendritic Cells
Chow, K. V., Delconte, R. B., Huntington, N. D., Tarlinton, D. M., Sutherland, R. M., Zhan, Y., & Lew, A. M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600181 · Cited by 23
CD47 as a potential prognostic marker for oral leukoplakia and oral squamous cell carcinoma
Xiaojing, Y., Wang, X., Lü, R., Zhang, J., Chen, X., & Zhou, G. (2018) · Oncology Letters · doi:10.3892/ol.2018.8520 · Cited by 23
Molecular functions of SIRPα and its role in cancer (Review)
Takahashi, S. (2018) · Biomedical Reports · doi:10.3892/br.2018.1102 · Cited by 24
Burgess, T. L., Amason, J., Rubin, J. S., Duveau, D. Y., Lamy, L., Roberts, D. D., Farrell, C. L., Inglese, J., Thomas, C. J., & Miller, T. W. (2020) · PLoS ONE · doi:10.1371/journal.pone.0226661 · Cited by 23
Kidder, K., Bian, Z., Shi, L., & Liu, Y. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000652 · Cited by 23
Novel fully human anti‐CD47 antibodies stimulate phagocytosis and promote elimination of AML cells
Wang, C., Sun, C., Li, M., Xia, B., Wang, Y., Zhang, L., Zhang, Y., Wang, J., Sun, F., Lü, S., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30163 · Cited by 23
Beizavi, Z., Hayat, S. M. G., Moghadasian, H., Zare, H., Yeganeh, B. S., Askari, H., Vakili, S., Tajbakhsh, A., & Savardashtaki, A. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06547-y · Cited by 23
Wu, F., Pang, H., Li, F., Hua, M., Song, C., & Tang, J. (2024) · Oncology Letters · doi:10.3892/ol.2024.14389 · Cited by 22
Zheng, L., Wang, H., Zhong, X., Lin, J. H., Shi, G., Bai, C., Yang, R., Huang, Z., Jiang, Y., Wei, J., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122809 · Cited by 22
Targeting myeloid cells with bispecific antibodies as novel immunotherapies of cancer
Sewnath, C. A. N., Behrens, L. M., & van Egmond, M. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2098675 · Cited by 22
Targeting CD47-SIRPα axis for Hodgkin and non-Hodgkin lymphoma immunotherapy
Zhao, P., Xie, L.-Y., Yu, L., & Wang, P. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.12.008 · Cited by 22
Role of Microenvironment in Non-Hodgkin Lymphoma
Khurana, A., & Ansell, S. M. (2020) · The Cancer Journal · doi:10.1097/ppo.0000000000000446 · Cited by 23
Sweet-Jones, J., Lenis, V. P. E., Yurchenko, A. A., Yudin, N. S., Swain, M., & Larkin, D. M. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.612492 · Cited by 22
Checkpoint CD47 expression in classical Hodgkin lymphoma
Gholiha, A. R., Hollander, P., Löf, L., Glimelius, I. C., Hedström, G., Molin, D. L., Hjalgrim, H., Smedby, K. E. E., Hashemi, J., Amini, R., et al. (2022) · British Journal of Haematology · doi:10.1111/bjh.18137 · Cited by 22
Cellular organelles as drug carriers for disease treatment
Hu, J., Liu, Y., Du, Y., Peng, X., & Liu, Z. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.09.038 · Cited by 22
Targeting the CD24-Siglec10 Axis: A Potential Strategy for Cancer Immunotherapy
Fang, J., Li, L., Cao, Y., Tan, J., Liang, Y., Xiao, X., Ouyang, N., Saw, P. E., & Yang, W. (2024) · BIO Integration · doi:10.15212/bioi-2023-0022 · Cited by 21
Zhang, B., Zou, Y., Tang, Q., Yuan, Z., Jiang, K., Zhang, Z., Chen, S., Wu, Q., Zhou, X., & Zhang, X. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03414-6 · Cited by 23
Qi, Y., Fu, Y., Wu, X., Chen, Z., Tang, Y., Ao, H., Zhu, H., Zou, C., Sun, B., Zheng, C., et al. (2025) · ACS Nano · doi:10.1021/acsnano.5c11552 · Cited by 23
Sakamoto, M., Murata, Y., Tanaka, D., Kakuchi, Y., Okamoto, T., Hazama, D., Saito, Y., Kotani, T., Ohnishi, H., Miyasaka, M., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2109923118 · Cited by 21
Engineering SIRPα cellular membrane-based nanovesicles for combination immunotherapy
Wang, M., Wang, Y., Mu, Y., Yang, F., Yang, Z., Liu, Y., Huang, L., Liu, S., Guan, X., Xie, Z., et al. (2023) · Nano Research · doi:10.1007/s12274-023-5397-4 · Cited by 21
Zhao, W., Shen, B., Cheng, Q., Zhou, Y., & Chen, K. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08357-w · Cited by 21
van Helden, M. J. G., Zwarthoff, S. A., Arends, R. J., Reinieren-Beeren, I., Paradé, M., Driessen-Engels, L., de Laat-Arts, K., Damming, D., Santegoeds-Lenssen, E. W. H., van Kuppeveld, D., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006567 · Cited by 23
Gitik, M., Elberg, G., Reichert, F., Tal, M., & Rotshenker, S. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02929-0 · Cited by 21
Quercetin Limits Tumor Immune Escape through PDK1/CD47 Axis in Melanoma
Li, X., He, X., Lin, B., Li, L., Deng, Q., Wang, C., Zhang, J., Chen, Y., Zhao, J., Li, X., et al. (2024) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x2450023x · Cited by 22
Radtke, S., Chan, Y. Y., Sippel, T. R., Kiem, H., & Rongvaux, A. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2018.12.003 · Cited by 21
Condemned or Not to Die? Gene Polymorphisms Associated With Cell Death in Pemphigus Foliaceus
Bumiller‐Bini, V., Cipolla, G. A., Spadoni, M. B., Augusto, D. G., Petzl‐Erler, M. L., Beltrame, M. H., & Boldt, A. B. W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02416 · Cited by 21
Yanagida, E., Miyoshi, H., Takeuchi, M., Yoshida, N., Nakashima, K., Yamada, K., Umeno, T., Shimasaki, Y., Furuta, T., Seto, M., et al. (2020) · Hematological Oncology · doi:10.1002/hon.2768 · Cited by 21
Sarute, N., Cheng, H., Yan, Z., Salas-Briceno, K., Richner, J. M., Rong, L., & Ross, S. R. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009662 · Cited by 21
Mezzapelle, R., Marchis, F. D., Passera, C., Leo, M., Brambilla, F., Colombo, F., Casalgrandi, M., Preti, A., Zambrano, S., Castellani, P., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202012344 · Cited by 21
Baumann, N., Rösner, T., Jansen, J. H. M., Chan, C., Eichholz, K. M., Klausz, K., Winterberg, D., Müller, K., Humpe, A., Burger, R., et al. (2021) · Cancer Science · doi:10.1111/cas.14999 · Cited by 21
Mechanisms of HIV-1 cell-to-cell transfer to myeloid cells
Han, M., Woottum, M., Mascarau, R., Vahlas, Z., Vérollet, C., & Bénichou, S. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.4mr0322-737r · Cited by 24
Salminen, A. (2024) · Biogerontology · doi:10.1007/s10522-024-10114-w · Cited by 22
Zhong, C., Wang, L., Hu, S., Huang, C., Xia, Z., Liao, J., Yi, W., & Chen, J. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.5ma0421-013r · Cited by 23
Wang, H., Newton, G. A., Wu, L., Lin, L., Miracco, A. S., Natesan, S., & Luscinskas, F. W. (2021) · JCI Insight · doi:10.1172/jci.insight.148719 · Cited by 21
Functions of glutaminyl cyclase and its isoform in diseases
Liu, Y., Shi, Y., & Wang, P. (2023) · Visualized Cancer Medicine · doi:10.1051/vcm/2022008 · Cited by 20
CD47 promotes peripheral T cell survival by preventing dendritic cell–mediated T cell necroptosis
Komori, S., Saito, Y., Nishimura, T., Respatika, D., Endoh, H., Yoshida, H., Sugihara, R., Iida‐Norita, R., Afroj, T., Takai, T., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2304943120 · Cited by 20
Santulli-Marotto, S., Gervais, A., Fisher, J., Strake, B., Ogden, C. A., Riveley, C., & Giles-Komar, J. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145078 · Cited by 20
Reglero-Real, N., García-Weber, D., & Millán, J. (2016) · Mediators of Inflammation · doi:10.1155/2016/7650260 · Cited by 20
Progress and perspectives on nanoplatforms for drug delivery to the brain
Xu, Y., Wei, L., & Wang, H. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101636 · Cited by 20
Tan, Y., Wu, Q., & Zhou, F. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.102993 · Cited by 20
CD27hiCD38hi plasmablasts are activated B cells of mixed origin with distinct function
Rouers, A., Appanna, R., Chevrier, M., Lum, J., Lau, M. C., Tan, L., Loy, T., Tay, A., Sethi, R., Sathiakumar, D., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102482 · Cited by 20
Engineering Strategies for Generating Hypoimmunogenic Cells with High Clinical and Commercial Value
Malik, N. N., Jenkins, A. M., Mellon, J., & Bailey, G. (2019) · Regenerative Medicine · doi:10.2217/rme-2019-0117 · Cited by 20
Signal regulatory protein α protects podocytes through promotion of autophagic activity
Li, L., Liu, Y., Li, S., Yang, R., Zeng, C., Rong, W., Liang, H., Zhang, M., Zhu, X., Kidder, K., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.124747 · Cited by 19
Li, Y., Zhu, T., Chen, J., Liu, K., Wei, C., Fang, Q., Huang, X., & Shan, H. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202401355 · Cited by 19
López‐Collazo, E., & Hurtado‐Navarro, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1524781 · Cited by 21
Metadata
- Authors
- Barclay, A. N., & van den Berg, T. K.
- Affiliations
- University of Oxford (GB)
- Sanquin Research and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, 1066 CX Amsterdam, The Netherlands;
- ORCID
- Barclay, A. Neil
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 2014-03-21
- Volume
- 32
- Issue
- 1
- Pages
- 25-50
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- OpenAlex
- W2139418176
- Cited by
- 841
- References
- 155
- Citations by year
- 2026: 63 · 2025: 107 · 2024: 108 · 2023: 84 · 2022: 77 · 2021: 89 · 2020: 89 · 2019: 51 · 2018: 44 · 2017: 60 · 2016: 32 · 2015: 26 · 2014: 11
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- CD47, SIRPα, don't eat me signal, phagocytosis, immune evasion, autoimmunity, host defense, cancer immunotherapy, inflammation, xenotransplantation, graft survival, receptor evolution
- MeSH terms
- Animals, Antigens, Differentiation, Autoimmune Diseases, Dendritic Cells, Multigene Family, Hematologic Diseases, Humans, Neoplasms, Phagocytosis, Protein Binding, Receptors, Immunologic, T-Lymphocytes, Signal Transduction, CD47 Antigen, Immunological Synapses, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review